Prevalence of Macroprolactin in Hyperprolactinemic Patients Receiving Anti-Psychotics

Loai Ali Al Mortada Al Wasify, Shaikha Said Al Maamary and Mohammed Nasser Rashid Al Tobi
Additional contact information
Shaikha Said Al Maamary: Al Masarra hospital, Laboratory Department, MOH, Sultanate of Oman
Mohammed Nasser Rashid Al Tobi: Sultan Qaboos University, College of Medicine, Laboratory Department, Sultanate of Oman

Biomedical Journal of Scientific & Technical Research, 2021, vol. 37, issue 4, 29500-29506

Abstract: Prolactin (PRL) hormone circulates in the blood in three forms, mono-prolactin which constitutes 85 % of prolactin in healthy and hyperprolactinemia conditions, dimeric prolactin.

Keywords: Covid-19; Infectious Disease; Disease Control; Incubation Period; Spread Rate of Covid-19; Population; Unemployment Tradeoff; Virus; Vaccines; Covid-19 Mutation (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006015.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006015.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:37:y:2021:i:4:p:29500-29506

DOI: 10.26717/BJSTR.2021.37.006015

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().